# EULAT Eradicate GBC: a European and Latin American consortium to prevent gallbladder cancer

Source: https://onco.cc/key-papers/paper-scherer-eulat-eradicate-gbc-ije-2025/  
OnCo record `paper-scherer-eulat-eradicate-gbc-ije-2025` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A data resource profile of a case-control study and biobank of 11,453 people with gallstones or gallbladder cancer in Argentina, Bolivia, Chile and Peru, 1,570 of them in Bolivia, built to find markers that predict who will develop the cancer.

## Summary

Published as "Data Resource Profile: EULAT Eradicate GBC: the European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer". Funded by the EU's Horizon 2020 programme, the consortium recruits people with gallstone disease before cholecystectomy, and people with gallbladder cancer, in four South American countries, and links them to large European cohorts. Samples of blood, saliva, urine, bile and stool are processed in more than 17 Chilean, 9 Peruvian, 4 Bolivian and 3 Argentinean centres. The paper has no abstract; the figures here are from its full text.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: International Journal of Epidemiology
- Year: 2025
- DOI: 10.1093/ije/dyaf127
- Authors: Scherer D, Barahona Ponce C, Mengoa C, et al.
- Findings: By March 2025, 11,453 Latin American participants were enrolled: 68% in Chile, 16% in Peru, 14% in Bolivia (1,570) and 2% in Argentina.; 74% of participants are women and the median age is 48; 1,033 have gallbladder cancer, 391 dysplasia and 10,029 gallstone disease.; Quechua is the most represented Indigenous ancestry (13%), followed by Mapuche (11%) and Aymara (5%).
- What it means: A resource for finding who among the many people with gallstones in the Andes should have their gallbladder removed before cancer develops; Bolivia, with GLOBOCAN's highest estimated gallbladder cancer rate, contributes about one participant in seven.
- Caveats: A description of a study resource, not results.; Most participants have gallstones rather than cancer, by design.

## Sources

- Int J Epidemiol 2025: https://doi.org/10.1093/ije/dyaf127
- PubMed: https://pubmed.ncbi.nlm.nih.gov/40735836/
- ClinicalTrials.gov: NCT06192719: https://clinicaltrials.gov/study/NCT06192719

## Connected records

- cancers: [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- institutions: [Ministerio de Salud y Deportes, Bolivia](https://onco.cc/institutions/bolivia-ministry-of-health/)

---
JSON: https://onco.cc/api/v1/entities/paper-scherer-eulat-eradicate-gbc-ije-2025.json